InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（5 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
5
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Lamy Patrick, See Remarks. Director active across 1 company, notably Akero Therapeutics, Inc.. Aggregated, 17 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €213k. History available since 8 December 2023. The latest transaction was disclosed on 1 July 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Lamy Patrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
3,059 股Common StockSEC:0001193125-25-312099:0
26,832 股Common StockSEC:0001193125-25-312099:1
2,000 股@ US$52.8813.9% 占其流量Common StockSEC:0000950170-25-094011:0
193 股@ US$23.8680.7% 占其流量Common StockSEC:0000950170-25-093320:0
875 股@ US$54.597.5% 占其流量Common StockSEC:0000950170-25-088639:0
2,000 股@ US$19.876.2% 占其流量Common StockSEC:0000950170-25-088206:0
919 股@ US$53.9999.1% 占其流量Common StockSEC:0000950170-25-085670:0
4,000 股@ US$19.8716.0% 占其流量Common StockSEC:0000950170-25-081774:0
4,000 股@ US$44.3743.2% 占其流量Common StockSEC:0000950170-25-077131:0
8,000 股@ US$19.8738.6% 占其流量Common StockSEC:0000950170-25-068392:0
1,000 股@ US$19.875.2% 占其流量Common StockSEC:0000950170-25-033997:0
234 股@ US$19.6861.2% 占其流量Common StockSEC:0000950170-25-010706:0
17,400 股0Common StockSEC:0000950170-24-138149:0
925 股@ US$30.797.4% 占其流量Common StockSEC:0000950170-24-136020:0
221 股@ US$19.9411.1% 占其流量Common StockSEC:0000950170-24-080923:0
569 股@ US$22.6413.3% 占其流量Common StockSEC:0000950170-24-073183:0
18,570 股0Common StockSEC:0000950170-23-069745:0
17 条申报中的 17 条
About Lamy Patrick
Patrick Lamy is involved in various functions at Akero Therapeutics, Inc. His role includes specific responsibilities that contribute to the development and strategy of the company. His expertise is an asset to the organization.
